Trial intelligence / Profile preview

INSIST-TNK: Intra-arterial TNK for Ischemic Stroke With Poor Recanalization After Thrombectomy

NCT04201964Recruiting

Start
Dec 2019
Primary completion
Jun 2028
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

Open-label, single-arm trial of tenecteplase in ischemic stroke. Primary endpoint: Proportion of sufficient recanalization. Started Dec 2019; status: recruiting.

02

Drugs

tenecteplase
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04201964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04201964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call